Skip to main content
NCBI home page
Heart logoLink to Heart
. 1996 May;75(5):447–450. doi: 10.1136/hrt.75.5.447

Abrupt cessation of short-term continuous treatment with isosorbide dinitrate may cause a rebound increase in silent myocardial ischaemia in patients with stable angina pectoris.

S Y Martsevich 1, N Koutishenko 1, V I Metelitsa 1
PMCID: PMC484339  PMID: 8665335

Abstract

OBJECTIVE: To examine by Holter electrocardiographic monitoring the effect of abruptly stopping nitrate treatment in patients with stable angina pectoris. PATIENTS: 12 men with confirmed ischaemic heart disease and stable exertional class 3 angina (Canadian). All had episodes of horizontal or down sloping ST segment depression during 24 hour electrocardiographic monitoring. All were nitrate responders. DESIGN: Each patient was given isosorbide dinitrate (10-30 mg four times a day) and placebo (four times a day) for three days in a randomised crossover trial. There was a washout period of 3-5 days between the two treatment periods. Holter monitoring was performed on the third day of isosorbide dinitrate and placebo administration and on the first day of their withdrawal. RESULTS: When treatment with isosorbide dinitrate was stopped there was a significant increase in the total number and duration of painless episodes of myocardial ischaemia. During placebo and isosorbide dinitrate administration 8 patients had episodes of painless myocardial ischaemia whereas after isosorbide dinitrate cessation they were recorded in all 12 patients. Episodes of silent myocardial ischaemia at rest appeared in 4 patients after isosorbide dinitrate withdrawal. CONCLUSION: Abrupt cessation of short-term continuous nitrate treatment in patients with severe angina may cause a rebound increase in myocardial ischaemia which is predominantly silent.

Full text

PDF
447

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abrams J. Nitrate tolerance and dependence. Am Heart J. 1980 Jan;99(1):113–123. doi: 10.1016/0002-8703(80)90321-x. [DOI] [PubMed] [Google Scholar]
  2. Bauer J. A., Fung H. L. Effect of apparent elimination half-life on nitroglycerin-induced hemodynamic rebound in experimental heart failure. Pharm Res. 1993 Sep;10(9):1341–1345. doi: 10.1023/a:1018930032203. [DOI] [PubMed] [Google Scholar]
  3. Blasini R., Froer K. L., Blümel G., Rudolph W. Wirkungsverlust von Isosorbiddinitrat bei Langzeitbehandlung der chronischen Herzinsuffizienz. Herz. 1982 Aug;7(4):250–258. [PubMed] [Google Scholar]
  4. Cowan J. C., Bourke J. P., Reid D. S., Julian D. G. Prevention of tolerance to nitroglycerin patches by overnight removal. Am J Cardiol. 1987 Aug 1;60(4):271–275. doi: 10.1016/0002-9149(87)90226-8. [DOI] [PubMed] [Google Scholar]
  5. DeMots H., Glasser S. P. Intermittent transdermal nitroglycerin therapy in the treatment of chronic stable angina. J Am Coll Cardiol. 1989 Mar 15;13(4):786–795. doi: 10.1016/0735-1097(89)90216-7. [DOI] [PubMed] [Google Scholar]
  6. Ferratini M., Pirelli S., Merlini P., Silva P., Pollavini G. Intermittent transdermal nitroglycerin monotherapy in stable exercise-induced angina: a comparison with a continuous schedule. Eur Heart J. 1989 Nov;10(11):998–1002. doi: 10.1093/oxfordjournals.eurheartj.a059425. [DOI] [PubMed] [Google Scholar]
  7. Freedman S. B., Daxini B. V., Noyce D., Kelly D. T. Intermittent transdermal nitrates do not improve ischemia in patients taking beta-blockers or calcium antagonists: potential role of rebound ischemia during the nitrate-free period. J Am Coll Cardiol. 1995 Feb;25(2):349–355. doi: 10.1016/0735-1097(94)00416-n. [DOI] [PubMed] [Google Scholar]
  8. Georgopoulos A. J., Markis A., Georgiadis H. Therapeutic efficacy of a new transdermal system containing nitroglycerin in patients with angina pectoris. Eur J Clin Pharmacol. 1982;22(6):481–485. doi: 10.1007/BF00609618. [DOI] [PubMed] [Google Scholar]
  9. Gottlieb S. O., Gottlieb S. H., Achuff S. C., Baumgardner R., Mellits E. D., Weisfeldt M. L., Gerstenblith G. Silent ischemia on Holter monitoring predicts mortality in high-risk postinfarction patients. JAMA. 1988 Feb 19;259(7):1030–1035. [PubMed] [Google Scholar]
  10. Gumbrielle T., Freedman S. B., Fogarty L., Ogasawara S., Sobb P., Kelly D. T. Efficacy, safety and duration of nitrate-free interval to prevent tolerance to transdermal nitroglycerin in effort angina. Eur Heart J. 1992 May;13(5):671–678. doi: 10.1093/oxfordjournals.eurheartj.a060234. [DOI] [PubMed] [Google Scholar]
  11. Juhani Knuuti M., Wahl M., Wiklund I., Smith P., Alhainen L., Härkönen R., Puska P., Tzivoni D. Acute and long-term effects on myocardial ischemia of intermittent and continuous transdermal nitrate therapy in stable angina. Am J Cardiol. 1992 Jun 15;69(19):1525–1532. doi: 10.1016/0002-9149(92)90697-w. [DOI] [PubMed] [Google Scholar]
  12. Kannel W. B. Detection and management of patients with silent myocardial ischemia. Am Heart J. 1989 Jan;117(1):221–226. doi: 10.1016/0002-8703(89)90686-8. [DOI] [PubMed] [Google Scholar]
  13. Klock J. C. Nonocclusive coronary disease after chronic exposure to nitrates: evidence for physiologic nitrate dependence. Am Heart J. 1975 Apr;89(4):510–513. doi: 10.1016/0002-8703(75)90159-3. [DOI] [PubMed] [Google Scholar]
  14. Martsevich S. Y., Koutishenko N., Metelitsa V. I. Withdrawal phenomenon after abrupt cessation of nifedipine in stable angina pectoris. Int J Cardiol. 1993 Dec 31;42(3):298–301. doi: 10.1016/0167-5273(93)90065-o. [DOI] [PubMed] [Google Scholar]
  15. Metelitsa V. I., Martsevich SYu, Kozyreva M. P., Slastnikova I. D. Enhancement of the efficacy of isosorbide dinitrate by captopril in stable angina pectoris. Am J Cardiol. 1992 Feb 1;69(4):291–296. doi: 10.1016/0002-9149(92)90222-k. [DOI] [PubMed] [Google Scholar]
  16. Metelitsa V. I., Martsevich SYu, Piotrovskii V. K., Ryabokon O. S., Blagodatskikh S. V. New transdermal and transmucosal nitroglycerin delivery systems in patients with ischaemic heart disease. Eur J Clin Pharmacol. 1987;32(1):5–10. doi: 10.1007/BF00609950. [DOI] [PubMed] [Google Scholar]
  17. Morton W. E. Occupational habituation to aliphatic nitrates and the withdrawal hazards of coronary disease and hypertension. J Occup Med. 1977 Mar;19(3):197–200. [PubMed] [Google Scholar]
  18. Nitrate therapy in stable angina pectoris. N Engl J Med. 1988 Jan 14;318(2):119–120. doi: 10.1056/NEJM198801143180213. [DOI] [PubMed] [Google Scholar]
  19. Rehnqvist N., Olsson G., Engvall J., Rosenqvist U., Nyberg G., Aberg A., Ulvenstam G., Uusitalo A., Keyriläinen O., Reinikainen P. Abrupt withdrawal of isosorbide-5-mononitrate in Durules (Imdur) after long term treatment in patients with stable angina pectoris. Eur Heart J. 1988 Dec;9(12):1339–1347. doi: 10.1093/oxfordjournals.eurheartj.a062452. [DOI] [PubMed] [Google Scholar]
  20. Rudolph W., Dirschinger J., Kraus F., Reiniger G., Hall D. Nitrate therapy in patients with coronary artery disease--preparations and doses with and without development of tolerance. Z Kardiol. 1990;79 (Suppl 3):57–65. [PubMed] [Google Scholar]
  21. Scardi S., Camerini F., Pandullo C., Pollavini G. Efficacy of continuous and intermittent transdermal treatment with nitroglycerin in effort angina pectoris: a multicentric study. The Collaborative Nitro Group. Int J Cardiol. 1991 Aug;32(2):241–248. doi: 10.1016/0167-5273(91)90331-i. [DOI] [PubMed] [Google Scholar]
  22. Schaer D. H., Buff L. A., Katz R. J. Sustained antianginal efficacy of transdermal nitroglycerin patches using an overnight 10-hour nitrate-free interval. Am J Cardiol. 1988 Jan 1;61(1):46–50. doi: 10.1016/0002-9149(88)91302-1. [DOI] [PubMed] [Google Scholar]
  23. Silber S., Vogler A. C., Krause K. H., Theisen K. The haemodynamic and anti-ischaemic effects of a single tablet of 80 mg isosorbide dinitrate in slow-release formulation and a review of nitrate tolerance. Drugs. 1987;33 (Suppl 4):69–79. doi: 10.2165/00003495-198700334-00014. [DOI] [PubMed] [Google Scholar]

Articles from Heart are provided here courtesy of BMJ Publishing Group

RESOURCES